


Searching News Database: MAP0004
HSMN NewsFeed - 26 May 2009
MAP Pharmaceuticals Phase 3 Trial of LEVADEX(TM) Migraine Product Candidate Meets All Four Primary Endpoints
MAP Pharmaceuticals Phase 3 Trial of LEVADEX(TM) Migraine Product Candidate Meets All Four Primary Endpoints
HSMN NewsFeed - 10 Aug 2007
MAP Pharmaceuticals Appoints Shashidhar Kori New Vice President of Clinical Development
MAP Pharmaceuticals Appoints Shashidhar Kori New Vice President of Clinical Development
HSMN NewsFeed - 10 Aug 2007
MAP Pharmaceuticals Promotes Stephen B. Shrewsbury to Position of Chief Medical Officer
MAP Pharmaceuticals Promotes Stephen B. Shrewsbury to Position of Chief Medical Officer
